{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:22:12Z","timestamp":1775686932533,"version":"3.50.1"},"reference-count":63,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"B\u00dcHLMANN Group"},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["852001930"],"award-info":[{"award-number":["852001930"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,7,7]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Children with chronic gastrointestinal symptoms are frequently seen in primary care, yet general practitioners (GPs) often experience challenges distinguishing functional gastrointestinal disorders (FGID) from organic disorders. We, therefore, aim to evaluate whether a test strategy that includes point-of-care testing (POCT) for faecal calprotectin (FCal) can reduce the referral rate to paediatric specialist care among children with chronic gastrointestinal symptoms. The study findings will contribute to improving the recommendations on FCal use among children in primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>In this pragmatic cluster randomised controlled trial, we will randomise general practices into intervention and control groups. The intervention group will use FCal-POCT when indicated, after completing online training about its indication, interpretation and follow-up as well as communicating an FGID diagnosis. The control group will test and treat according to Dutch GP guidelines, which advise against FCal testing in children. GPs will include children aged 4\u201318 years presenting to primary care with chronic diarrhoea and\/or recurrent abdominal pain. The primary outcome will be the referral rate for children with chronic gastrointestinal symptoms within 6 months after the initial assessment. Secondary outcomes will be evaluated by questionnaires completed at baseline and at 3- and 6-month follow-up. These outcomes will include parental satisfaction and concerns, gastrointestinal symptoms, impact of symptoms on daily function, quality of life, proportion of children with paediatrician-diagnosed FGID referred to secondary care, health service use and healthcare costs. A sample size calculation indicates that we need to recruit 158 GP practices to recruit 406 children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The Medical Research Ethics Committee (MREC) of the University Medical Center Groningen (The Netherlands) approved this study (MREC number: 201900309). The study results will be made available to patients, GPs, paediatricians and laboratories via peer-reviewed publications and in presentations at (inter)national conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>The Netherlands Trial Register: NL7690 (Pre-results)<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-045444","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T13:36:33Z","timestamp":1627047393000},"page":"e045444","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of faecal calprotectin testing on referrals for children with chronic gastrointestinal symptoms in primary care: study protocol for a cluster randomised controlled trial"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8744-8224","authenticated-orcid":false,"given":"Sophie","family":"Ansems","sequence":"first","affiliation":[{"name":"General Practice and Elderly Care Medicine, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"Berger","sequence":"additional","affiliation":[{"name":"General Practice and Elderly Care Medicine, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick Ferry","family":"van Rheenen","sequence":"additional","affiliation":[{"name":"Paediatric Gastroenterology, University Medical Centre Groningen Beatrix Childrens Hospital, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Vermeulen","sequence":"additional","affiliation":[{"name":"Epidemiology, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Beugel","sequence":"additional","affiliation":[{"name":"General Practice and Elderly Care Medicine, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Couwenberg","sequence":"additional","affiliation":[{"name":"General Practice and Elderly Care Medicine, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6579-767X","authenticated-orcid":false,"given":"Gea","family":"Holtman","sequence":"additional","affiliation":[{"name":"General Practice and Elderly Care Medicine, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"2025121410215271000_11.7.e045444.1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1268"},{"key":"2025121410215271000_11.7.e045444.2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-11-27"},{"key":"2025121410215271000_11.7.e045444.3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02813432.2013.844405","article-title":"Prevalence, characteristics, and management of childhood functional abdominal pain in general practice","volume":"31","author":"Spee","year":"2013","journal-title":"Scand J Prim Health Care"},{"key":"2025121410215271000_11.7.e045444.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.015"},{"key":"2025121410215271000_11.7.e045444.5","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31815bc1c1"},{"key":"2025121410215271000_11.7.e045444.6","doi-asserted-by":"publisher","DOI":"10.1097\/00001610-200601000-00009"},{"key":"2025121410215271000_11.7.e045444.7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2931"},{"key":"2025121410215271000_11.7.e045444.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.027"},{"key":"2025121410215271000_11.7.e045444.9","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081015","article-title":"Extraintestinal manifestations of celiac disease: early detection for better long-term outcomes","volume":"10","author":"Laurikka","year":"2018","journal-title":"Nutrients"},{"key":"2025121410215271000_11.7.e045444.10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ecco-jcc\/jjaa197","article-title":"Diagnostic delay is associated with complicated disease and growth impairment in paediatric Crohn\"s disease","volume":"15","author":"Ricciuto","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2025121410215271000_11.7.e045444.11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7378","article-title":"Association between steroid-sparing therapy and the risk of perianal Fistulizing complications among young patients with Crohn disease","volume":"3","author":"Adler","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025121410215271000_11.7.e045444.12","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0140-6736(17)30317-3","article-title":"Prediction of complicated disease course for children newly diagnosed with Crohn\"s disease: a multicentre inception cohort study","volume":"389","author":"Kugathasan","year":"2017","journal-title":"Lancet"},{"key":"2025121410215271000_11.7.e045444.13","first-page":"404","article-title":"NHG-Standaard Buikpijn bij kinderen","volume":"55","author":"Gieteling","year":"2012","journal-title":"Huisarts Wet"},{"key":"2025121410215271000_11.7.e045444.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189111","article-title":"Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care","volume":"12","author":"Holtman","year":"2017","journal-title":"PLoS One"},{"key":"2025121410215271000_11.7.e045444.15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2126"},{"key":"2025121410215271000_11.7.e045444.16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1865"},{"key":"2025121410215271000_11.7.e045444.17","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsj054"},{"key":"2025121410215271000_11.7.e045444.18","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1949"},{"key":"2025121410215271000_11.7.e045444.19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1177\/0009922817744607","article-title":"Utility of fecal calprotectin in evaluation of chronic gastrointestinal symptoms in primary care","volume":"57","author":"Ramraj","year":"2018","journal-title":"Clin Pediatr"},{"key":"2025121410215271000_11.7.e045444.20","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-317823"},{"key":"2025121410215271000_11.7.e045444.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-017-0578-9","article-title":"Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study","volume":"17","author":"Ludvigsson","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"2025121410215271000_11.7.e045444.22","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp18X698033"},{"key":"2025121410215271000_11.7.e045444.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005611"},{"key":"2025121410215271000_11.7.e045444.24","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmw018"},{"key":"2025121410215271000_11.7.e045444.25","doi-asserted-by":"crossref","DOI":"10.1093\/fampra\/cmw079","article-title":"Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms","volume":"154","author":"Holtman","year":"2016","journal-title":"Fam Pract"},{"key":"2025121410215271000_11.7.e045444.26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.cgh.2017.06.007","article-title":"Agreement between home-based measurement of stool calprotectin and ELISA results for monitoring inflammatory bowel disease activity","volume":"15","author":"Heida","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121410215271000_11.7.e045444.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214751","article-title":"Head-To-Head comparison of three stool calprotectin tests for home use","volume":"14","author":"Haisma","year":"2019","journal-title":"PLoS One"},{"key":"2025121410215271000_11.7.e045444.28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-8-15"},{"key":"2025121410215271000_11.7.e045444.29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121410215271000_11.7.e045444.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5661"},{"key":"2025121410215271000_11.7.e045444.31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF03089284","article-title":"NHG-Standaard Voedselovergevoeligheid | NHG","volume":"53","author":"Lucassen","year":"2010","journal-title":"Huisarts Wet"},{"key":"2025121410215271000_11.7.e045444.32","first-page":"103","article-title":"NHG-Standaard acute diarree |NHG","volume":"3","author":"Bruhl","year":"2007","journal-title":"Huisarts Wet"},{"key":"2025121410215271000_11.7.e045444.33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/BF03089256","article-title":"NHG-Standaard Obstipatie | NHG","volume":"53","author":"Diemel","year":"2010","journal-title":"Huisarts Wet"},{"key":"2025121410215271000_11.7.e045444.34","unstructured":"B\u00dcHLMANN Laboratories AG . Intended use. In: IBDoc manual. version 4. Sch\u00f6nenbuch. 3. In, 2019."},{"key":"2025121410215271000_11.7.e045444.35","unstructured":"Kirkpatrick DL . Evaluation of Training. In: Training and development Handbook. New York: McGraw Hillbook Company, 1967: 40\u201360."},{"key":"2025121410215271000_11.7.e045444.36","doi-asserted-by":"crossref","unstructured":"Roca M , Rodriguez Varela A , Carvajal E , et al . Fecal calprotectin in healthy children aged 4\u201316 years. Sci Rep 2020;10.doi:10.1038\/s41598-020-77625-7","DOI":"10.1038\/s41598-020-77625-7"},{"key":"2025121410215271000_11.7.e045444.37","article-title":"[Point-of-care-testing in general practice]","volume":"159","author":"Hopstaken","year":"2015","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2025121410215271000_11.7.e045444.38","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-198603000-00003"},{"key":"2025121410215271000_11.7.e045444.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2005.08.007"},{"key":"2025121410215271000_11.7.e045444.40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-1"},{"key":"2025121410215271000_11.7.e045444.41","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31816c4372"},{"key":"2025121410215271000_11.7.e045444.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.12.002"},{"key":"2025121410215271000_11.7.e045444.43","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-010-9648-y"},{"key":"2025121410215271000_11.7.e045444.44","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-010-9649-x"},{"key":"2025121410215271000_11.7.e045444.45","doi-asserted-by":"crossref","unstructured":"Bouwmans C , Hakkaart-van Roijen L . Handleiding iMTA productivity cost questionnaire (iPCQ). Rotterdam: iMTA, Erasmus Universiteit, 2013.","DOI":"10.1016\/j.jval.2014.08.1791"},{"key":"2025121410215271000_11.7.e045444.46","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv113"},{"key":"2025121410215271000_11.7.e045444.47","unstructured":"Hakkaart-van Roijen L , Van der Linden N , Bouwmans C . Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg.In opdracht van Zorginstituut Nederland. Geactualiseerde versie 2015."},{"key":"2025121410215271000_11.7.e045444.48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39500.677199.AE"},{"key":"2025121410215271000_11.7.e045444.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.09.018"},{"key":"2025121410215271000_11.7.e045444.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.10.003"},{"key":"2025121410215271000_11.7.e045444.51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-10"},{"key":"2025121410215271000_11.7.e045444.52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7418.785"},{"key":"2025121410215271000_11.7.e045444.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2011.01700.x"},{"key":"2025121410215271000_11.7.e045444.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2003.12.013"},{"key":"2025121410215271000_11.7.e045444.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2018.03.010"},{"key":"2025121410215271000_11.7.e045444.56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4006"},{"key":"2025121410215271000_11.7.e045444.57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2147"},{"key":"2025121410215271000_11.7.e045444.58","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2013.13"},{"key":"2025121410215271000_11.7.e045444.59","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2011.13.2\/npatsopoulos"},{"key":"2025121410215271000_11.7.e045444.60","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmq099"},{"key":"2025121410215271000_11.7.e045444.61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015295"},{"key":"2025121410215271000_11.7.e045444.62","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3812-7","article-title":"Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool","volume":"20","author":"Forbes","year":"2019","journal-title":"Trials"},{"key":"2025121410215271000_11.7.e045444.63","doi-asserted-by":"publisher","DOI":"10.1080\/00365540410019372"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-045444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:21:59Z","timestamp":1765736519000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-045444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,23]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bmjopen-2020-045444"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-045444","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}